These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9274708)

  • 21. Successful treatment with sodium valproate of a patient with Cushing's disease and gross enlargement of the pituitary.
    Koppeschaar HP; Croughs RJ; van't Verlaat JW; Hendriks MJ; Arts CJ; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):471-5. PubMed ID: 6097074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An infant with Cushing's disease due to an adrenocorticotropin-producing pituitary adenoma.
    Miller WL; Townsend JJ; Grumbach MM; Kaplan SL
    J Clin Endocrinol Metab; 1979 Jun; 48(6):1017-25. PubMed ID: 221523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cushing's syndrome 1985: current views and possibilities].
    Müller J
    Schweiz Med Wochenschr; 1986 Mar; 116(9):262-5. PubMed ID: 3485307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and pathophysiology of Cushing's syndrome.
    Gabrilove JL; Krakoff LR
    Compr Ther; 1986 Jan; 12(1):17-21. PubMed ID: 3004801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine function in patients with Cushing's disease before and after treatment.
    Lindholm J
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):151-9. PubMed ID: 1314723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
    Colombo P; Passini E; Re T; Faglia G; Ambrosi B
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinico-pathological study of Cushing's disease with large pituitary adenoma.
    Ikeda H; Yoshimoto T; Ogawa Y; Mizoi K; Murakami O
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):669-79. PubMed ID: 9274697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
    Comtois R; Beauregard H; Hardy J; Robert F; Somma M
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
    Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cushing's disease caused by adrenocortical nodular hyperplasia--diagnosis and surgical treatment].
    Miura M; Matsukado Y; Kodama T; Hiramatsu R
    No Shinkei Geka; 1984 May; 12(6):689-96. PubMed ID: 6087181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The treatment of Cushing's syndrome by selective excision of pituitary adenoma. 3 cases (author's transl)].
    Riviere J; Manciet G; Roger P; Guerin J; Barraud AM; Mauriac L; Kern AM; Rashedi M
    Nouv Presse Med; 1979 Jun; 8(27):2255-9. PubMed ID: 226930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indications and future perspectives in the pharmacological treatment of hypercortisolism].
    Stigliano A; Toscano V
    Recenti Prog Med; 2016 Mar; 107(3):143-8. PubMed ID: 27030224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma ACTH-response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test.
    Catania A; Cantalamessa L; Orsatti A; Mosca G; Minonzio F; Motta P; Reschini E; Zanussi C
    Metabolism; 1984 May; 33(5):478-81. PubMed ID: 6325850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclical Cushing's syndrome--a trap for the unwary.
    Loh KC
    Singapore Med J; 1999 Apr; 40(4):321-4. PubMed ID: 10487094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cushing's syndrome with a large pituitary adenoma producing both corticotropin-releasing hormone (CRH) and adrenocorticotropin (ACTH).
    Yamada Y; Ohashi A; Inoue T; Sakaguchi K; Tsujimura T; Okamoto D; Itatani H; Fujimoto N; Kusaka K; Fushimi H
    Intern Med; 2002 Jul; 41(7):549-54. PubMed ID: 12132523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cushing's syndrome caused by an ectopic pituitary adenoma.
    Schteingart DE; Chandler WF; Lloyd RV; Ibarra-Perez G
    Neurosurgery; 1987 Aug; 21(2):223-7. PubMed ID: 2821448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the accuracy of inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome].
    Tóth M; Vajda Z; Görömbey Z; Molnár F; Major L; Toke J; Szabolcs I; Szücs N; Kovács L; Kiss R; Czirják S; Füto L; Gláz E; Góth M; Rácz K
    Orv Hetil; 2007 May; 148(18):843-7. PubMed ID: 17468067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.